Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Efendic

Showing results (41-50 of 223) with videos related to

Pageof 23
Sort By:
Lakartidningen|March 25, 1999
[Gastrointestinal peptides among new therapeutic agents used in type 2 diabetes]S Efendic, T Bystedt, C G Ostenson
Journal of Internal Medicine. Supplement|January 1, 1991
Mechanisms involved in the regulation of the insulin secretory processS Efendic, H Kindmark, P O Berggren
Endocrinology|June 1, 1989
Pancreastatin-like immunoreactivity and insulin are released in parallel from the perfused porcine pancreasC G Ostenson, S Efendic, J J Holst
Acta Diabetologica|June 1, 1995
Relationship between insulin responses to D-glucose and to L-arginine in women with a history of gestational diabetesM Alvarsson, A Wajngot, S Efendic, et al.
Hepato-Gastroenterology|June 1, 1992
Can somatostatin prevent injection pancreatitis after ERCP?B Persson, P Slezak, S Efendic, et al.
Diabetologia|September 15, 2005
K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 yearsM Alvarsson, A Wajngot, E Cerasi, et al.
Diabetes Care|September 1, 1994
Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMIK A Malmberg, S Efendic, L E Rydén
Acta Endocrinologica|September 1, 1989
Impaired somatostatin response to orally administered glucose in type II diabetes entails both somatostatin-28 and -14 and is associated with deranged metabolic controlM Gutniak, V Grill, A Roovete, et al.
Acta Endocrinologica|April 1, 1988
Cholecystokinin-33 potentiates and vasoactive intestinal polypeptide inhibits gastric inhibitory polypeptide--induced insulin secretion in the perfused rat pancreasE Sandberg, B Ahrén, D Tendler, et al.
Metabolism: Clinical and Experimental|July 1, 1991
The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatmentK Brismar, V Grill, S Efendic, et al.
Pageof 23

Showing results (41-50 of 223) with videos related to

Sort By:
Pageof 23
Lakartidningen|March 25, 1999
[Gastrointestinal peptides among new therapeutic agents used in type 2 diabetes]S Efendic, T Bystedt, C G Ostenson
Journal of Internal Medicine. Supplement|January 1, 1991
Mechanisms involved in the regulation of the insulin secretory processS Efendic, H Kindmark, P O Berggren
Endocrinology|June 1, 1989
Pancreastatin-like immunoreactivity and insulin are released in parallel from the perfused porcine pancreasC G Ostenson, S Efendic, J J Holst
Acta Diabetologica|June 1, 1995
Relationship between insulin responses to D-glucose and to L-arginine in women with a history of gestational diabetesM Alvarsson, A Wajngot, S Efendic, et al.
Hepato-Gastroenterology|June 1, 1992
Can somatostatin prevent injection pancreatitis after ERCP?B Persson, P Slezak, S Efendic, et al.
Diabetologia|September 15, 2005
K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 yearsM Alvarsson, A Wajngot, E Cerasi, et al.
Diabetes Care|September 1, 1994
Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMIK A Malmberg, S Efendic, L E Rydén
Acta Endocrinologica|September 1, 1989
Impaired somatostatin response to orally administered glucose in type II diabetes entails both somatostatin-28 and -14 and is associated with deranged metabolic controlM Gutniak, V Grill, A Roovete, et al.
Acta Endocrinologica|April 1, 1988
Cholecystokinin-33 potentiates and vasoactive intestinal polypeptide inhibits gastric inhibitory polypeptide--induced insulin secretion in the perfused rat pancreasE Sandberg, B Ahrén, D Tendler, et al.
Metabolism: Clinical and Experimental|July 1, 1991
The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatmentK Brismar, V Grill, S Efendic, et al.
Pageof 23